Peer-Review Report of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9063)
All Articles published online
|
Publishing Process of This Article
|
Nov 21, 2024 (publication date) through Apr 28, 2026
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Guney-Coskun M, Basaranoglu M. Interplay of gut microbiota, glucagon-like peptide receptor agonists, and nutrition: New frontiers in metabolic dysfunction-associated steatotic liver disease therapy. World J Gastroenterol 2024; 30(43): 4682-4688 [PMID: 39575401 DOI: 10.3748/wjg.v30.i43.4682] |
|
|
|
| All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply. | |
| For: | Guney-Coskun M, Basaranoglu M. Interplay of gut microbiota, glucagon-like peptide receptor agonists, and nutrition: New frontiers in metabolic dysfunction-associated steatotic liver disease therapy. World J Gastroenterol 2024; 30(43): 4682-4688 [PMID: 39575401 DOI: 10.3748/wjg.v30.i43.4682] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v30/i43/4682.htm |
| Number | Citing Articles |
| 1 |
Boris Dinkov, Diana Pendicheva-Duhlenska. The Interplay Between GLP-1-Based Therapies, the Gut Microbiome, and MASLD/MASH in Type 2 Diabetes Mellitus: A Narrative Review. Biomedicines 2026; 14(4): 806 doi: 10.3390/biomedicines14040806
|
| 2 |
Mario Romeo, Claudio Basile, Giuseppina Martinelli, Fiammetta Di Nardo, Carmine Napolitano, Alessia De Gregorio, Paolo Vaia, Luigi Di Puorto, Mattia Indipendente, Alessandro Federico, Marcello Dallio. Beyond Insulin Resistance: Exploring the Centrality of the Gut–Liver Axis in Mediating Immunometabolic Dysregulation Driving Hepatocellular Carcinoma in MASLD and Diabetes. Cancers 2026; 18(8): 1316 doi: 10.3390/cancers18081316
|
| 3 |
Danyang Zhang, Haitao Shi, Chongcao Wei, Fenrong Chen, Pan Zhang, Xin Gao, Yan Wang. Analysis of causal effects on metabolic syndrome and inflammatory bowel disease: a Mendelian randomization study. Diabetology & Metabolic Syndrome 2025; 17(1) doi: 10.1186/s13098-025-01704-w
|
| 4 |
Afianti Sulastri, Dewi Cakrawati, Aldi Maulana Azis. Organ-Specific Modulation of IGF-Binding Proteins in Malnourished Mice Supplemented with Probiotics: A Proteomic Approach. BIO Web of Conferences 2026; 209: 03001 doi: 10.1051/bioconf/202620903001
|
| 5 |
Jiali Wu, Yusheng Qiu, Jiaying Deng, Yangpeng Li, Biao Jia, Zheng Cao, Jiaqing Tao, Jiao Guo. Faecal microbiota transplantation and glucolipid metabolic disorders: the interventional role of gut microbiota. Frontiers in Endocrinology 2026; 17 doi: 10.3389/fendo.2026.1806638
|
| 6 |
Junmei Huang, Hao Cheng. Effects of Bifidobacterium on metabolic parameters in overweight or obesity adults: a systematic review and meta-analysis. Frontiers in Microbiology 2025; 16 doi: 10.3389/fmicb.2025.1633434
|
| 7 |
Luigi Barrea, Giuseppe Annunziata, Ludovica Verde, Martina Galasso, Silvia Savastano, Annamaria Colao, Giovanna Muscogiuri. A Multidisciplinary Perspective on Semaglutide Treatment and Medical Nutrition Therapy in Obesity Management. Current Obesity Reports 2025; 14(1) doi: 10.1007/s13679-025-00667-3
|
| 8 |
Mehmet Kanbay, Rama Al-Shiab, Ermeena Shah, Lasin Ozbek, Mustafa Guldan, Alberto Ortiz, Denis Fouque. Gut microbiota modulation in GLP-1RA and SGLT-2i therapy: clinical implications and mechanistic insights in type 2 diabetes. Clinical Kidney Journal 2025; 18(12) doi: 10.1093/ckj/sfaf351
|
| 9 |
Jingyue Wang, Jing Qu, Mengliang Ye, Ru Feng, Xiang Hui, Xinyu Yang, Jingyu Jin, Qian Tong, Xianfeng Zhang, Yan Wang. Beyond conventional therapies: Gut microbiota modulation and macromolecular drugs in the battle against cardiometabolic diseases. Journal of Pharmaceutical Analysis 2026; 16(1): 101416 doi: 10.1016/j.jpha.2025.101416
|
| 10 |
Shengnan Meng, Luonan Li, Shijie Yin, Yuxuan Zhao, Yaning Liu, Yuxi Zhang, Xiaolin Zhang, Fengxue Yu. The newly proposed dietary index for gut microbiota and its association with the risk of nonalcoholic fatty liver disease: the mediating role of body mass index. Diabetology & Metabolic Syndrome 2025; 17(1) doi: 10.1186/s13098-025-01801-w
|
| 11 |
Luis A. Rodríguez-Rojas, Leticia Bucio-Ortiz, Verónica Souza-Arroyo, María Concepción Gutiérrez-Ruiz, Luis E. Gómez-Quiroz, Roxana U. Miranda-Labra. Cholesterol and the gut-liver axis: unraveling their role in the onset and progression of metabolic-associated steatotic liver disease. Exploration of Digestive Diseases 2025; doi: 10.37349/edd.2025.100583
|
| 12 |
Xueting Zheng, Xiaoyan Luo, Yi Zhang, Zhiyan Zou, Jiayi Yang, Huan Liu, Zhou Lu, Fangfang Cao, Xilian Wang, Xinyun Ge, Xiaoan Li, Jiali Wang. Inflammation in Diabetic Kidney Disease Is Linked to Gut Dysbiosis and Metabolite Imbalance. Journal of Diabetes 2025; 17(12) doi: 10.1111/1753-0407.70175
|
| 13 |
Hao Zhang, Yuan Tian, Chunjie Xu, Miaomiao Chen, Zeyu Xiang, Lei Gu, Hanbing Xue, Qing Xu. Crosstalk between gut microbiotas and fatty acid metabolism in colorectal cancer. Cell Death Discovery 2025; 11(1) doi: 10.1038/s41420-025-02364-5
|
| 14 |
Antonio Gasbarrini, Francesca Sofia Galli, Gianluca Ianiro, Francesca Ponziani, Emanuele Rinninella. The Enterolimbic Axis: Gut-Brain Affective Circuits at the Crossroad of Metabolism, Emotion, and Behavior. American Journal of Gastroenterology 2026; doi: 10.14309/ajg.0000000000003907
|
| 15 |
Houda Zoubiri, Wassila Saiah, Amel Otmane, Hamza Saidi, Mohamed Makrelouf, Samir Ait Abderrhmane, Ali El Mahdi Haddam, Elhadj-Ahmed Koceir. Plasma GLP-1 (Glucagon-like Peptide-1) Depletion Is Correlated with Dysregulation of Adipocytokine in Type 2 Diabetic Patients With or Without Metabolic-Associated Fatty Liver Disease (MAFLD): A Cross-Sectional Study Related to Gender-Sex Disparities. International Journal of Molecular Sciences 2026; 27(3): 1218 doi: 10.3390/ijms27031218
|